Erythrocytapheresis as a Novel Treatment Option for Adult Patients With Pyruvate Kinase Deficiency

Haematologica - Italy
doi 10.3324/haematol.2020.246686
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Pyruvate Kinase Deficiency

2008English

Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus

Baylor University Medical Center Proceedings
Medicine
2006English

Neutrophil Pyruvate Kinase Deficiency With Recurrent Staphylococcal Infections: First Reported Case.

BMJ
1976English

Pazopanib: A Novel Treatment Option for Aggressive Fibromatosis

Clinical Sarcoma Research
Oncology
2016English

Pyruvate Kinase Deficiency Protects Against Malaria in Humans

Haematologica
Hematology
2008English

181: A Patient With Pyruvate Carboxylase Deficiency

Pediatric Research
Child HealthPediatricsPerinatology
1976English

Guided Imagery as a Treatment Option for Fatigue

Journal of Holistic Nursing
Nursing
2011English

Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

Differential Effect of DCA Treatment on the Pyruvate Dehydrogenase Complex in Patients With Severe PDHC Deficiency

Pediatric Research
Child HealthPediatricsPerinatology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy